Navigation Links
Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be Presented as a Late-Breaking Poster at the 2011 American College of Rheumatology Annual Meeting
Date:10/27/2011

uch as decreased hemoglobin, fatigue, and osteoporosis.

About Regeneron PharmaceuticalsRegeneron is a fully integrated biopharmaceutical company that discovers, develops, manufacturers, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, which is approved for the treatment of a rare inflammatory condition, Regeneron has completed Phase 3 clinical trials of rilonacept for a new indication and of product candidates EYLEA™ (aflibercept injection; VEGF Trap-Eye) in diseases of the eye, and ZALTRAP® (aflibercept;VEGF Trap) in colorectal cancer.  EYLEA is currently under review with U.S. and European regulatory authorities.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis, pain, cholesterol reduction, allergic and immune conditions, and cancer.  Additional information about Regeneron and recent news releases are available on www.regeneron.com

Forward Looking StatementsThis news release includes forward-looking statements that involve risks and uncertainties relating to future events and the future financial performance of Regeneron, and actual events or results may differ materially from these forward-looking statements.  These statements concern, and these risks and uncertainties include, among others, the nature, timing, and possible success and therapeutic applications of Regeneron's product candidates and research and clinical programs now underway or planned, the likelihood and timing of possible regulatory approval and commercial launch of Regeneron's late-stage product candidates, determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to devel
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe
2. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
3. Hydrocodone and Oxycodones Lead U.S. General Workforce Positives, Outranked Only by Marijuana, According to Quest Diagnostics Drug Testing Index™
4. Hepatitis C Phase 2A Trial Positive Results
5. Daval International Announces Positive Phase II Results for AIMSPRO® as a Monotherapy in Established Diffuse Cutaneous Systemic Sclerosis (Scleroderma)
6. Echo Therapeutics Announces Positive Results of Clinical Trial of Its Symphony® Continuous Glucose Monitoring System
7. NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress
8. Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
9. Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation.
10. ALIMTA Receives Positive Opinion From CHMP as Continuation Maintenance Therapy for Deadly Form of Lung Cancer
11. Clermont Pharmaceuticals Reports Positive Phase III Results for Drug to Treat Glaucoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 24, 2014 Announced at the ... , the agreement seeks to increase access to a promising ... the AIDS 2014 conference in Melbourne ... agreement with Gilead Sciences for tenofovir alafenamide (TAF), a promising ... allow manufacturers in India and ...
(Date:7/23/2014)... NORWALK, Conn. , July 23, 2014 ... NeurologyTimes.com – a new online community and information ... them better manage and treat their patients with ... conditions, coupled with an aging population, necessitates greater access ... specific disorders.  Key statistics on neurological conditions include: ...
(Date:7/23/2014)... MOUNTAIN VIEW, Calif. , July 23, ... in translational preclinical research, today unveiled their new logo ... the transformation of Surpass, corporate culture to one where ... customers. This press release comes on the heels of ... added to the Silicon Valley Team:  David Craig, a ...
Breaking Medicine Technology:The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF) 2The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF) 3UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 2SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 3
... Gamma Pharmaceuticals, Inc. (PINKSHEETS: GMPM.PK) a marketing and ... for everyday health and wellness, announced this afternoon, ... Order for the Company,s 17-gram Gamma Energy GEL.  ... value.  Gamma will support sales with point of ...
...   Cerecor Inc. , a biopharmaceutical company focused on ... primary activity is in the human nervous system, today ... FP01 for the treatment of cough has cleared the ... Drug Administration (FDA).  The Company plans to immediately characterize ...
Cached Medicine Technology:Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™ 2Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™ 3Cerecor Announces Clearance of IND for FP01 2
(Date:7/24/2014)... Colo. (PRWEB) July 24, 2014 ... Prepared to Identify and Prevent the Three Infections ... Infections?’ is a go-to guide to help ... risk factors and details basic prevention measures that ... The e-book is available for download at ...
(Date:7/24/2014)... Novato, CA (PRWEB) July 24, 2014 The ... to unveil a new CARDAMOM CRÈME BRÛLÉE TEA to celebrate ... Steven Spielberg, Oprah Winfrey and Juliet Blake. A hundred-foot journey ... familiar and cross over into a new realm that is ... journey, however small in physical distance that materially changes the ...
(Date:7/24/2014)... Info Cash 2, the latest video training course developed ... to help the average person learn how to build their ... Shane Michaels, prompting an investigative review. , Watch ... talk to knows that it’s possible to build their business ... actually start doing it because for some reason they think ...
(Date:7/24/2014)... San Jose, California (PRWEB) July 24, 2014 ... market for sugar alcohols, commonly known as food polyols, ... confectionery sectors. Rising incidence of obesity, growing ... rapidly aging population vulnerable to diabetes are some of ... market. With growing number of scientific studies validating the ...
(Date:7/24/2014)... NJ (PRWEB) July 24, 2014 Losing a ... – overwhelming sadness as well as shock, fear, guilt, anger, ... spouse's death agonizing and confusing. It may be small comfort ... temporary but it is in fact the case that grieving ... says clinical psychologist Dr. Hayley Hirschmann of ...
Breaking Medicine News(10 mins):Health News:New E-book Helps Nurses Identify and Prevent Three Most Common Healthcare Associated Infections 2Health News:New E-book Helps Nurses Identify and Prevent Three Most Common Healthcare Associated Infections 3Health News:The Republic of Tea Unveils New Tea Inspired by “The Hundred-Foot Journey” 2Health News:The Republic of Tea Unveils New Tea Inspired by “The Hundred-Foot Journey” 3Health News:Top Info Cash 2.0: Review Examines Chris Carpenter’s New and Updated Video Training Course 2Health News:Rising Incidence of Diabetes and Obesity Drives the Global Sugar Alcohols Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of Diabetes and Obesity Drives the Global Sugar Alcohols Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 2Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 3Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 4
... , , Patients Cite Affordability ... WASHINGTON , Feb. 11 A new ... care reform has not gone away.  Many heart disease and ... system, with nearly two-thirds citing affordability as the top concern ...
... , LAKEWOOD, Colo. , Feb. 11 ... its Board of Directors has declared a regular quarterly cash dividend ... on March 15, 2010 to shareholders of record at ... Mesa Laboratories develops, acquires, manufactures and markets electronic instruments and disposables ...
... often recognize signs that their child is about to have ... occurs, researchers at Washington University School of Medicine in St. ... Annals of Allergy, Asthma and Immunology, show there ... child,s symptoms, possibly reduce the extent of the attack and ...
... First ... ... von Furstenberg today announces the establishment of The DVF Awards to recognize women whose ... women around the world. Supported by The Diller-von Furstenberg Family Foundation, The DVF ...
... improved sleep for patients with chronic neck or back ... interfered with their daily functioning, according to a study ... study, published online by the journal Sleep Medicine, ... who already are taking medications for pain and might ...
... Neb. , Feb. 11 Sergeant,s Pet Care ... to improve human dental health for two revolutionary new products ... the Petrodex® Tooth-Hugger Toothbrush. The Petrodex Tooth-Hugger Toothbrush is currently ... Veterinary Cleaning Paste will be available in pet specialty stores ...
Cached Medicine News:Health News:New American Heart Association Survey Finds Heart Disease and Stroke Patients Face Significant Barriers in Obtaining Quality, Affordable Care 2Health News:New American Heart Association Survey Finds Heart Disease and Stroke Patients Face Significant Barriers in Obtaining Quality, Affordable Care 3Health News:Parents often wait too long to treat children's asthma symptoms 2Health News:Parents often wait too long to treat children's asthma symptoms 3Health News:Diane von Furstenberg Establishes The DVF Awards to Recognize Outstanding Women Leaders 2Health News:Behavioral therapy improves sleep and lives of patients with pain 2Health News:Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeant's Pet Care Products, Inc. 2Health News:Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeant's Pet Care Products, Inc. 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: